Biochemical diagnosis of liver damage in patients with hemophilia
Demidova, N.V.; Boborykina, T.N.; Koniashina, N.I.
Gematologiia i Transfuziologiia 34(6): 18-20
1989
ISSN/ISBN: 0234-5730 PMID: 2806860 Document Number: 335936
The complexes of the controlling and informative biochemical tests are offered. They are scientifically validated criteria for early identification of the disorders of renal function and differentiation between the syndromes of its damage in the course of the disease.
Document emailed within 1 workday
Related Documents
Lutze, G.; Schlote, A.; Beyer, H.; Kropf, S. 1985: Diagnosis of hemophilia and Willebrand-Jürgens syndrome. 2. Results of studies in hemophilia patients and hemophilia carriers Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 40(16): 479-483Mehnert, E. 1987: The use of infrared spectroscopy of liver biopsies for the diagnosis of liver damage in cattle Archiv für Experimentelle Veterinarmedizin 41(4): 584-589
Sumimoto, K.; Inagaki, K.; Ito, H.; Marubayashi, S.; Yamada, K.; Kawasaki, T.; Dohi, K. 1987: Ischemic damage prevention by coenzyme Q10 treatment of the donor before orthotopic liver transplantation: biochemical and histologic findings Surgery 102(5): 821-827
Pryzjemski, J.; Wlasiuk, M.; Chrostowska, H. 1976: Assessment of the gluconeogenetic function of the liver on the basis of blood lactate elimination in patients with acute and chronic liver damage Przeglad Lekarski 33(12): 979-983
Ambriz-Fernández, R.; Reyna-Fregoso, M.P.; Pizzuto-Chávez, J.; Rodríguez-Moyado, H.; Farfán-Canto, J.M.; Trueba-Christy, E.; Collazo-Jaloma, J. 1985: Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. a study of the cooperative group of hemophilia Archivos de Investigacion Medica 16(3): 225-235
Denić, K.; Tarabar, D.; Obradovic, S.; Ristić, M.; Spasić, J.; Radosavljević, D.; Ugrešić, N. 2016: Biochemical liver function test parameter levels in relation to treatment response in liver metastatic colorectal patients treated with FOLFOX4 with or without bevacizumab Srpski Arhiv Za Celokupno Lekarstvo 144(11-12): 615-620
Breithaupt, H. 1994: Drug-induced liver damage caused by antirheumatic drugs--antirheumatic therapy in pre-existing liver damage Zeitschrift für Rheumatologie 53(4): 250-254
Stránský, J.; Polomis, V.; Lomská, L.; Kaspárková, J.; Vodák, M.; Sprincl, L. 1981: Clinical, biochemical, scintigraphic and histological diagnosis of advanced liver steatosis Vnitrni Lekarstvi 27(2): 105-114
Brotons Brotons, B.; Villar Grimalt, A.; González López, O.; Carratala Huesa, R.; Roman Sánchez, P.; Gil Suay, V.; García Paumard, J. 1981: Gammaglutamyl transpeptidase and other biochemical parameters in the diagnosis of liver disease. Discriminant statistical study Revista Clinica Espanola 160(4): 241-246
Girolami, A.; Burul, A.; Cappellato, G.; Dal Bo Zanon, R. 1979: Electroimmunoassay of factor IX in patients with liver damage and vitamin K unresponsive coagulation disorder Folia Haematologica 106(1): 65-71
Pashintseva, L.P.; Krusanova, N.I.; Assekritova, I.V. 1970: Some data from a biochemical study of patients with primary cancer of the liver during chemotherapy Vestnik Akademii Meditsinskikh Nauk SSSR 25(2): 39-43
Pashintseva, L.P.; Demina, E.A.; Pirogova, N.A. 1981: Certain biochemical parameters of blood serum in patients with liver metastases of lymphogranulomatosis Terapevticheskii Arkhiv 53(9): 62-65
Vaubourdolle, M.; Chazouillères, O.; Briaud, I.; Legendre, C.; Serfaty, L.; Poupon, R.; Giboudeau, J. 1995: Plasma alpha-glutathione S-transferase assessed as a marker of liver damage in patients with chronic hepatitis C Clinical Chemistry 41(12 Part 1): 1716-1719
Bokhan, N.A.; Abolonin, A.F.; Ankudinova, I.É; Kurgak, D.I.; Mandel', A.I. 2012: Use of remaxol in the combination therapy of post-withdrawal disorders in alcoholic patients with comorbid liver damage Terapevticheskii Arkhiv 84(10): 51-55
Pulatov, D.A. 2002: Dynamics of clinical and biochemical indices in patients with primary liver cancer during endovascular chemotherapy Likars'ka Sprava 7: 80-82
Mehta, M.N.; Patel, M.C.; Joseph, L.J.; Velumani, A.; Desai, K.B. 1988: Serum thyroid hormone levels in patients with liver damage: evidence of multiple abnormalities in presence of euthyroidism Journal of the Association of Physicians of India 36(11): 637-639
Marlicz, W.; Wunsch, E.; Mydlowska, M.; Milkiewicz, M.; Serwin, K.; Mularczyk, M.; Milkiewicz, P.; Raszeja-Wyszomirska, J. 2016: The effect of short term treatment with probiotic VSL#3 on various clinical and biochemical parameters in patients with liver cirrhosis Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 67(6): 867-877
Więcek, S.; Woś, H.; Kordys-Darmolińska, Bżena.; Sankiewicz-Szkółka, M.; Grzybowska-Chlebowczyk, U. 2015: Does the mutation of the SERPINA1 gene contribute to liver damage and cholestasis in patients with diagnosed cystic fibrosis? preliminary study Developmental Period Medicine 19(1): 92-97
Jelić, D.; Jelić, O. 1994: The HBe antigen-antibody system and its relationship to epidemiological, histological and biochemical findings in patients with HBV+ HDV chronic liver diseases Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(2): 77-83
Kaszewska-Jablońska, I. 1971: Iron and protein in subcellular fractions of the liver during acute and chronic liver damage Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 26(Suppl 22): 311-312